Your browser doesn't support javascript.
loading
CYP2D6 Polymorphisms and the Safety and Gametocytocidal Activity of Single-Dose Primaquine for Plasmodium falciparum.
Pett, Helmi; Bradley, John; Okebe, Joseph; Dicko, Alassane; Tiono, Alfred B; Gonçalves, Bronner P; Stone, Will; Chen, Ingrid; Lanke, Kjerstin; Neuvonen, Mikko; Mustaniemi, Anna-Liina; Eziefula, Alice C; Gosling, Roly; D'Alessandro, Umberto; Drakeley, Chris; Niemi, Mikko; Bousema, Teun.
Afiliação
  • Pett H; Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Bradley J; Department of Clinical Pharmacology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Okebe J; MRC Tropical Epidemiology Group, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Dicko A; Medical Research Council Unit the Gambia at the London School of Hygiene and Tropical Medicine, Banjul, the Gambia.
  • Tiono AB; Malaria Research and Training Centre, Faculty of Pharmacy and Faculty of Medicine and Dentistry, University of Science, Techniques and Technologies of Bamako, Bamako, Mali.
  • Gonçalves BP; Public Health Department, Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
  • Stone W; Department of Immunology and Infection, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Chen I; Department of Immunology and Infection, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Lanke K; Malaria Elimination Initiative, Global Health Group, University of California, San Francisco, San Francisco, California, USA.
  • Neuvonen M; Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Mustaniemi AL; Department of Clinical Pharmacology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Eziefula AC; Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Gosling R; Department of Forensic Medicine, University of Helsinki, Helsinki, Finland.
  • D'Alessandro U; Department of Immunology and Infection, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Drakeley C; Brighton and Sussex Centre for Global Health Research, Brighton and Sussex Medical School, University of Sussex, Brighton, United Kingdom.
  • Niemi M; Malaria Elimination Initiative, Global Health Group, University of California, San Francisco, San Francisco, California, USA.
  • Bousema T; Medical Research Council Unit the Gambia at the London School of Hygiene and Tropical Medicine, Banjul, the Gambia.
Antimicrob Agents Chemother ; 63(10)2019 10.
Article em En | MEDLINE | ID: mdl-31383656
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Plasmodium falciparum / Polimorfismo Genético / Primaquina / Malária Falciparum / Citocromo P-450 CYP2D6 / Deficiência de Glucosefosfato Desidrogenase / Antimaláricos Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Plasmodium falciparum / Polimorfismo Genético / Primaquina / Malária Falciparum / Citocromo P-450 CYP2D6 / Deficiência de Glucosefosfato Desidrogenase / Antimaláricos Idioma: En Ano de publicação: 2019 Tipo de documento: Article